MARKET

CMND

CMND

Clearmind Medici
NASDAQ
1.255
+0.015
+1.21%
Closed 19:14 04/15 EDT
OPEN
1.290
PREV CLOSE
1.240
HIGH
1.290
LOW
1.200
VOLUME
25.40K
TURNOVER
0
52 WEEK HIGH
24.67
52 WEEK LOW
0.9205
MARKET CAP
4.09M
P/E (TTM)
-0.0406
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CMND last week (0408-0412)?
Weekly Report · 22h ago
CLEARMIND MEDICINE FILES U.S. PATENT APPLICATION FOR PSYCHEDELIC-BASED TREATMENT FOR EATING DISORDERS
Reuters · 5d ago
Clearmind Medicine CEO Issues Letter to Shareholders
Clearmind Medicine Inc. Is a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics. The Company's CEO, Dr. Adi Zuloff-Shani, sent a letter to shareholders. Clearmind is a company that aims to solve major under-treated health problems.
Barchart · 04/09 07:07
Weekly Report: what happened at CMND last week (0401-0405)?
Weekly Report · 04/08 11:11
Weekly Report: what happened at CMND last week (0325-0329)?
Weekly Report · 04/01 11:09
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Benzinga's psychedelic headlines roundup includes news from the last two weeks of March 2024. Psychedelic therapy as a form of life and the role of psychedelics in the management of chronic pain are among the topics. A new study shows psilocybin is a prodrug of psilocin. Frank Herbert’s magic mushrooms are available in Canada.
Benzinga · 03/30 12:57
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Utah hospitals will soon provide psilocybin and MDMA therapy for mental health conditions in a pilot program. Beckley Psytech and atai announce positive initial results from a clinical trial of 5-MeO-DMT in Treatment Resistant Depression. Prosecutors in Virginia are probing whether Facebook's social media platforms are facilitating the illegal sale of drugs. Elon Musk makes the case for using psychedelics in a new episode of the Benzinga Psychedelics Podcast.
Benzinga · 03/29 16:43
BRIEF-Clearmind Medicine Announces International Patent Application For Preventing, Treating Depression
Reuters · 03/27 13:12
More
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.

Webull offers Clearmind Medicine Inc stock information, including NASDAQ: CMND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMND stock methods without spending real money on the virtual paper trading platform.